サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1433315

経カテーテル肺動脈弁の世界市場：2023～2030年

Global Transcatheter Pulmonary Valve Market 2023-2030
出版日: | 発行: Orion Market Research | ページ情報: 英文 205 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.98円
経カテーテル肺動脈弁の世界市場：2023～2030年
出版日: 2023年12月08日
発行: Orion Market Research
ページ情報: 英文 205 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の経カテーテル肺動脈弁の市場規模は、2023～2030年の予測期間中にCAGR 7.3％で成長すると予測されています。市場成長の主な要因としては、リウマチ性心疾患、高血圧性心疾患、脳血管疾患、炎症性心疾患など、さまざまな心血管疾患（CVD）の有病率の増加が挙げられます。心臓弁疾患の人口増加や肺動脈弁置換術の需要急増は、市場成長を支える主な要因です。世界保健機関（WHO）によると、2019年には推定1,790万人がCVDで死亡し、世界の死亡者数の32%を占めます。リウマチ性心疾患は毎年28万8,348人以上の命を奪っており、その大部分は低所得国または中所得国です。世界で30歳から79歳の推定12億8,000万人の成人が高血圧であり、そのうちの約3分の2が低・中所得国に住んでいます。また、高血圧の成人の推定46％は、自分が高血圧であることに気づいていないです。

セグメント別の展望

バルーン拡張型経カテーテル弁は、世界の経カテーテル肺動脈弁市場で大きなシェアを占めると予想されます。

製品の中では、バルーン拡張型経カテーテル弁のサブセグメントが予測期間中に成長すると予想されます。このセグメントの成長は、バルーン拡張型経カテーテル弁の採用率の増加、製品開発数の増加、技術進歩に起因しています。そのため、メーカーはバルーン拡張技術の製造に関心を寄せており、これが市場の成長を後押ししています。エルゼビアJACC.Asiaジャーナルが発表した論文によると、JACC：Asia誌が2021年9月にThe American College of Cardiology Foundationに代わって発表した論文によると、新世代のバルーン拡張型弁（BEV）は、特に二尖大動脈弁の有病率が高い一部のアジア諸国において、手術に代わる有効な選択肢となるようです。BEVに適用される汎用性の高い技術は、脳室周囲白質軟化症（PVL）、冠動脈閉塞、プロトンポンプ阻害薬（PPI）、大動脈破裂のリスクが高いためTAVRでは不適格とされていた、異常、重度に石灰化した、より大きな環状のBAVを安全に治療することができます。

地域別展望

世界の経カテーテル肺動脈弁市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他の欧州）、アジア太平洋（インド、中国、日本、韓国、その他のアジア太平洋）、その他の地域（中東・アフリカ、ラテンアメリカ）を含む地域別にさらに区分されます。中でもアジア太平洋は、革新的な心臓弁に対する需要の高まり、老人人口の増加、ヘルスケア支出の増加により、予測期間中に成長すると予測されています。

北米地域は経カテーテル肺動脈弁の世界市場で大きなCAGRで成長する見込み

北米は、肺動脈狭窄症や肺動脈逆流症などの疾患の有病率の上昇とともに、発達したヘルスケアセクターの存在により、経カテーテル肺動脈弁市場で大きなシェアを占めると予想されます。さらに、革新的な心臓弁に対する意識の高まりと需要の増加、医療費の増加は、予測期間中の市場成長を促進すると予測される他の要因です。経済協力開発機構（OECD）によると、2021年、米国は国内総生産（GDP）の17.8％をヘルスケアに費やしており、これはOECD諸国の平均の約2倍です。

Centers for Medicare & Medicaid Services (CMMS)が2022年3月に発表したデータによると、国民医療費の年間成長率は2021年から2030年にかけて平均5.1％、2030年には約6兆8,000億米ドルに達すると予想されています。GDPの成長率も同期間で年率5.1％と予測されています。GDPに占めるヘルスケアの割合は2030年には19.6％となり、2020年の19.7％とほぼ同じになります。したがって、同国におけるヘルスケア支出の増加は、効率的な経カテーテル肺動脈弁の開発における企業活動や政府のイニシアチブを後押しし、ひいては市場の成長を後押しすると予想されます。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • Boston Scientific Corp.
  • Braile Biomedica
  • Medtronic PLC
  • Edwards Lifesciences Corp.
  • 主要戦略分析

第4章 市場セグメンテーション

  • 経カテーテル肺動脈弁の世界市場：技術別
    • バルーン拡張型経カテーテル弁
    • 自己拡張型経カテーテル弁
  • 経カテーテル肺動脈弁の世界市場：用途別
    • 心臓異常
    • 肺閉鎖症
    • 肺動脈狭窄
    • 肺逆流
    • その他

第5章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他の欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他のアジア太平洋
  • その他の地域

第6章 企業プロファイル

  • 4C Medical Technologies, Inc.,
  • Abott laboratories
  • Artivion, Inc.
  • Colibri Heart Valve, LLC
  • Cryolife, Inc.
  • Direct Flow Medical, Inc.
  • JenaValve Technology, Inc.
  • Jude Medical Inc.
  • Labcor Laborateries Ltd.
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • LivaNova PLC
  • St. Jude Medical, Inc.
  • SYMETIS SA
  • Venus Medtech（Hangzhou）Inc.
  • Xeltis B.V.
図表

LIST OF TABLES

  • 1. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 2. GLOBAL BALLOON-EXPANDED TRANSCATHETER VALVE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL SELF-EXPANDED TRANSCATHETER VALVE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 5. GLOBAL TRANSCATHETER PULMONARY VALVE FOR CARDIAC ANOMALY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL TRANSCATHETER PULMONARY VALVE FOR PULMONARY ATRESIA MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL TRANSCATHETER PULMONARY VALVE FOR PULMONARY STENOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL TRANSCATHETER PULMONARY VALVE FOR PULMONARY REGURGITATION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL TRANSCATHETER PULMONARY VALVE FOR OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. NORTH AMERICAN TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 12. NORTH AMERICAN TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 13. NORTH AMERICAN TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 14. EUROPEAN TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 15. EUROPEAN TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 16. EUROPEAN TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 17. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 18. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 19. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 20. REST OF THE WORLD TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 21. REST OF THE WORLD TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 22. REST OF THE WORLD TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SHARE BY TECHNOLOGY, 2022 VS 2030 (%)
  • 2. GLOBAL BALLOON-EXPANDED TRANSCATHETER VALVE MARKET SHARE BY MATERIAL, 2022 VS 2030 (%)
  • 3. GLOBAL SELF-EXPANDED TRANSCATHETER VALVE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022 VS 2030 (%)
  • 5. GLOBAL TRANSCATHETER PULMONARY VALVE FOR CARDIAC ANOMALY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL TRANSCATHETER PULMONARY VALVE FOR PULMONARY ATRESIA MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL TRANSCATHETER PULMONARY VALVE FOR PULMONARY STENOSIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL TRANSCATHETER PULMONARY VALVE FOR PULMONARY REGURGITATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL TRANSCATHETER PULMONARY VALVE FOR OTHER APPLICATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. US TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
  • 12. CANADA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
  • 13. UK TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. FRANCE TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. GERMANY TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. ITALY TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. SPAIN TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. REST OF EUROPE TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. INDIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. CHINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. JAPAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. SOUTH KOREA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. REST OF ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. REST OF THE WORLD TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027939

Global Transcatheter Pulmonary Valve Market Size, Share & Trends Analysis Report by Technology (Balloon-Expanded Transcatheter Valve, and Self-Expanded Transcatheter Valve), and by Application (Cardiac Anomaly, Pulmonary Atresia, Pulmonary Stenosis, Pulmonary Regurgitation, and Others), Forecast Period (2023-2030)

The global transcatheter pulmonary valve market is anticipated to grow at a CAGR of 7.3% during the forecast period (2023-2030). Pivotal factors attributed to market growth including increasing prevalence of various cardiovascular diseases (CVDs) such as rheumatic heart disorders, hypertensive heart diseases, cerebrovascular diseases, and inflammatory heart diseases. The growing population with heart valve disorders and surging demand for pulmonary valve replacement are major factors supporting the market growth. According to the World Health Organization (WHO), an estimated 17.9 million people were deceased from CVDs in 2019, representing 32% of all global mortalities. Rheumatic heart disease and claims over 288,348 lives each year the large majority in low- or middle-income countries. An estimated 1.28 billion adults aged 30 to 79 years globally have hypertension, among which around two-thirds living in low and middle-income countries. In addition, an estimated 46% of adults with hypertension are unaware that they have the condition.

Segmental Outlook

The global transcatheter pulmonary valve market is segmented on the technology, and application. Based on the technology, the market is sub-segmented into balloon-expanded transcatheter valve and self-expanded transcatheter valve. Further, based on application, the market is sub-segmented into cardiac anomaly, pulmonary atresia, pulmonary stenosis, pulmonary regurgitation, and others. Where, others include tetralogy of fallot, truncusarteriosus. Among the application, the pulmonary stenosis sub-segment is anticipated to hold a considerable share of the market, owing to its enhanced feasibility of treating both aortic stenosis and aortic regurgitation with low rates of procedural complications.

The Balloon-Expanded Transcatheter Valve Sub-Segment is Anticipated to Hold a Considerable Share of the Global Transcatheter Pulmonary Valve Market

Among the products, balloon-expanded transcatheter valve sub-segment is expected to grow over the forecast period. The segmental growth is attributed to the increasing adoption rate for balloon-expanded transcatheter valve and the growing number of product development, and technical advancement. Thus, manufacturers are attracted towards manufacturing balloon-expanded technology which in turn is propelling the market growth. According to the article published by Elsevier JACC: Asia journal, on behalf of The American College of Cardiology Foundation, in September 2021, new-generation balloon-expandable valve (BEV) appeared to be a valid alternative to surgery, especially in some Asian countries with a higher prevalence of bicuspid aortic valve. Versatile techniques applied to BEV could treat anomaly, heavily calcified, larger annular BAVs safely, which were considered ineligible in TAVR due to high risk of Periventricular leukomalacia (PVL), coronary artery obstruction, Proton pump inhibitors (PPIs), and aortic rupture.

Regional Outlook

The global transcatheter pulmonary valve market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, the Asia-Pacific region is anticipated to grow over the forecast period, owing to the growing demand for innovative heart valves, increasing geriatric population, and rising healthcare expenditure.

The North America Region is Expected to Grow at a Significant CAGR in the Global Transcatheter Pulmonary Valve Market

North America is expected to hold a prominent share in the transcatheter pulmonary valve market, owing to the presence of a well-developed healthcare sector, along with the rising prevalence of disorders such as pulmonary stenosis and regurgitation. Additionally, rising awareness and increasing demand for innovative heart valves, along with the rising healthcare expenditure are some other factors projected to drive the market growth over the forecast period. According to the Organization for Economic Co-operation and Development (OECD), in 2021, the US spent 17.8% of gross domestic product (GDP) on healthcare, nearly twice as much as the average OECD country.

As per the data published by the Centers for Medicare & Medicaid Services (CMMS), in March 2022, the report found that annual growth in national health spending is expected to average 5.1% over 2021-2030, and will reach nearly $6.8 trillion by 2030. Growth in the nation's GDP is also projected to be 5.1% annually over the same period. As a result of the comparable projected rates of growth, the healthcare share of GDP is expected to be 19.6% in 2030, nearly the same as the 2020 share of 19.7%. Thus, the growing healthcare spending in the country is anticipated to push company activities and government initiatives in developing efficient transcatheter pulmonary valves, in turn bolstering the market growth.

Market Players Outlook

The major companies serving the global transcatheter pulmonary valve market include Boston Scientific Corp., Braile Biomedica, Medtronic PLC, Edwards Lifesciences Corp., Artivion, Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in February 2023, Medtronic PLC relaunched first-of-its-kind transcatheter pulmonary valve replacement system for treating congenital heart disease.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global transcatheter pulmonary valve market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Boston Scientific Corp.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Braile Biomedica
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Medtronic PLC
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Edwards Lifesciences Corp.
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Transcatheter Pulmonary Valve Market by Technology
    • 4.1.1. Balloon-Expanded Transcatheter Valve
    • 4.1.2. Self-Expanded Transcatheter Valve
  • 4.2. Global Transcatheter Pulmonary Valve Market by Application
    • 4.2.1. Cardiac Anomaly
    • 4.2.2. Pulmonary Atresia
    • 4.2.3. Pulmonary Stenosis
    • 4.2.4. Pulmonary Regurgitation
    • 4.2.5. Others (Tetralogy of Fallot, Truncus Arteriosus)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. 4C Medical Technologies, Inc.,
  • 6.2. Abott laboratories
  • 6.3. Artivion, Inc.
  • 6.4. Colibri Heart Valve, LLC
  • 6.5. Cryolife, Inc.
  • 6.6. Direct Flow Medical, Inc.
  • 6.7. JenaValve Technology, Inc.
  • 6.8. Jude Medical Inc.
  • 6.9. Labcor Laborateries Ltd.
  • 6.10. Lepu Medical Technology (Beijing) Co., Ltd.
  • 6.11. LivaNova PLC
  • 6.12. St. Jude Medical, Inc.
  • 6.13. SYMETIS SA
  • 6.14. Venus Medtech (Hangzhou) Inc.
  • 6.15. Xeltis B.V.